T1	Participants 77 173	hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy.
T2	Participants 471 552	patients with type 2 diabetes exhibiting inadequate glycemic control (A1C 7-11%).
T3	Participants 646 737	302 patients with type 2 diabetes (mean A1C 8.3%) on metformin monotherapy (mean 1.5 g/day)
T4	Participants 1767 1854	patients with type 2 diabetes who had inadequate glycemic control with metformin alone.
T5	Participants 1963 1979	type 2 diabetes.
